Avista Capital Partners has announced it has signed a definitive agreement to invest in eMolecules.
eMolecules, based in San Diego, is provider of high-value, hard-to-find chemicals and bioreagents used in early-stage drug discovery research. Founded in 2005, the company connects pharmaceutical and biotechnology researchers with reagents not offered by the usual commodity suppliers.